Mitochondrial DNA editing offers new hope for neurodegenerative disease treatment

Mitochondrial DNA (mtDNA) editing has emerged as a revolutionary approach in the fight against neurodegenerative diseases (NDDs). As these diseases continue to impose a significant global health burden, the innovative use of mitochondrial gene editing …

The Inheritance Nobody Wants: How Alzheimer's Steals Futures Before It Claims Memories

AFOF Sets $2 Million Fundraising Goal to Expand Caregiver Support in 2025 NAPERVILLE, IL / ACCESS Newswire / May 12, 2025 / As the number of families affected by Alzheimer's disease continues to grow, so does the financial and emotional …

HIV Drugs Dramatically Lower Risk of Alzheimer's Disease, Study Finds

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to treat HIV and hepatitis B. Along with their antiretroviral effects, drugs called nucleoside reverse transcriptase inhibitors …

3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons

By Krishna Macha, Carole Crittenden, and Oksana Sirenko, Molecular Devices, LLC, and Rebecca Fiene, Scott Schachtele, Coby Carlson, FUJIFILM Cellular Dynamics, Inc. This content is brought to you by Molecular Devices, a Danaher Operating Company. The …

How I care for Alzheimer's disease: Living for every moment is 'all we have'

“I took him home, and his shoulder was completely bruised,” said Joy. “He said he thought he fell in the night, and I took him to the emergency room.” It turned out Chris’s collarbone was broken. Joy assumed that her husband was acting out of sorts due to …

Drug to Slow Alzheimer's Well Tolerated Outside of Clinical Trial Setting

Newswise — The Food and Drug Administration’s approval in 2023 of lecanemab — a novel Alzheimer’s therapy shown in clinical trials to modestly slow disease progression — was met with enthusiasm by many in the field as it represented the first medication of …

Scientists find molecule that blocks brain cell death in Parkinson's, Alzheimer's

Sydney, May 12 : A team of Australian scientists has identified a small molecule that blocks cell death, an advance that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team from the Melbourne- …

Tiziana Life Sciences reports significant reduction in microglia activation in PET scan of moderate Alzheimer's patient ...

Tiziana Life Sciences, Ltd., a biotechnology company, announced results of a PET scan showing a marked reduction in microglia activation associated with neuroinflammation in a patient suffering from moderate Alzheimer’s disease (AD) who was treated for …

Scientists discover molecule that halts brain cell death in Parkinson's, Alzheimer's

SYDNEY, May 12 (Xinhua) -- Scientists have identified a small molecule that blocks cell death, offering hope for treatments that could slow or stop the progression of neurodegenerative diseases like Parkinson's and Alzheimer's, a leading Australian …

The fear (and guilt) of living overseas from a parent with Alzheimer's disease